Inhal Pharma

Ningbo City, China · Founded 2020 · Privately Held (backing)

Developer of a dry powder inhalation platform designed to advance formulation development, inhaler design, and inhaled drug manufacturing. Inhal Pharma is based in Ningbo City, China and was founded in 2020. It has raised $29.5 million.

Last price · $/share
—
Implied valuation
—
Total raised
$29.5M
Last round
—

Who backs Inhal Pharma?

13 investors
InvestorType
Beijing State-owned Capital Operation and ManagementOther
Shun Xi FundPE / buyout
Saiying CapitalOther
Zhangzhou Pien Tze Huang Investment ManagementOther
Ascentage Pharma—
Beijing Science Sun Pharmaceutical Company—
CBC Group (Singapore)—
Chongqing Zhifei Biological Products Company—
Grains Valley Venture Capital—
Menovo—
+ 3 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Inhal Pharma investors

Free account
More of Inhal Pharma with a free account
  • ·The complete investor list: 13 names
  • ·Watch Inhal Pharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 13 firms already write checks for companies like Inhal Pharma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View